Evidence map›Paper›PMID 24718306›Full record

ArticlePloS one2014

Association between health systems performance and treatment outcomes in patients co-infected with MDR-TB and HIV in KwaZulu-Natal, South Africa: implications for TB programmes.

Marian Loveday, Nesri Padayatchi, Kristina Wallengren, Jacquelin Roberts, James C M Brust, Jacqueline Ngozo, Iqbal Master, Anna Voce

Abstract readMulticenter Study
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Quality of TB care among people living with HIV: Gaps and solutions.Journal of clinical tuberculosis and other mycobacterial diseases · 2019
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Sharing the spotlight in Durban: A report from IAS TB2016 at AIDS2016.Journal of clinical tuberculosis and other mycobacterial diseases · 2017
    Article
  15. Review
  16. Review
  17. Observational
  18. Observational
  19. Observational
  20. Community-based care vs. centralised hospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marian LovedayHealth Systems Research Unit, South African Medical Research Council, Cape Town, South Africa.
Nesri PadayatchiCentre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.
Kristina WallengrenTuberculosis & HIV Investigative Network of KwaZulu-Natal (THINK), Durban, South Africa.
Jacquelin RobertsRetired from Centres for Disease Control and Prevention, Atlanta, Georgia, United States of America.
James C M BrustDepartment of Medicine, Montefiore Medical Center & Albert Einstein College of Medicine, Bronx, New York, United States of America.
Jacqueline NgozoKwaZulu-Natal Department of Health, Pietermaritzburg, South Africa.
Iqbal MasterKing Dinuzulu Hospital Complex, KwaZulu-Natal Department of Health, Durban, South Africa.
Anna VoceDiscipline of Public Health Medicine, University of KwaZulu-Natal, Durban, South Africa.

Funding

Integrated, Home-based Treatment for MDR TB and HIV in Rural South AfricaK23AI083088 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI BRUST, JAMES C M · 2010 to 2014
$665k
NIAID NIH HHS K23 AI083088NIAID NIH HHS K23AI083088
6 · The paper itself

Abstract

objectiveTo improve the treatment of MDR-TB and HIV co-infected patients, we investigated the relationship between health system performance and patient treatment outcomes at 4 decentralised MDR-TB sites.

methodsIn this mixed methods case study which included prospective comparative data, we measured health system performance using a framework of domains comprising key health service components. Using Pearson Product Moment Correlation coefficients we quantified the direction and magnitude of the association between health system performance and MDR-TB treatment outcomes. Qualitative data from participant observation and interviews analysed using systematic text condensation (STC) complemented our quantitative findings.

findingsWe found significant differences in treatment outcomes across the sites with successful outcomes varying from 72% at Site 1 to 52% at Site 4 (p<0.01). Health systems performance scores also varied considerably across the sites. Our findings suggest there is a correlation between treatment outcomes and overall health system performance which is significant (r = 0.99, p<0.01), with Site 1 having the highest number of successful treatment outcomes and the highest health system performance. Although the 'integration' domain, which measured integration of MDR-TB services into existing services appeared to have the strongest association with successful treatment outcomes (r = 0.99, p<0.01), qualitative data indicated that the 'context' domain influenced the other domains.

conclusionWe suggest that there is an association between treatment outcomes and health system performance. The chance of treatment success is greater if decentralised MDR-TB services are integrated into existing services. To optimise successful treatment outcomes, regular monitoring and support are needed at a district, facility and individual level to ensure the local context is supportive of new programmes and implementation is according to guidelines.

Indexed as

Anti-HIV AgentsAntitubercular AgentsAttitude of Health PersonnelCatchment Area, HealthCoinfectionDelivery of Health CareDisease ManagementDrug Resistance, BacterialDrug Resistance, MultipleDrug Resistance, ViralHIV InfectionsHumansPoliticsProspective StudiesQualitative ResearchQuality Indicators, Health CareAnti-HIV AgentsAntitubercular Agents

Identifiers

PMID24718306
PMCPMC3981751

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.